| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 4,439 | $55.00 | $244,145.00 | View Details Filing |
| Mar 9, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 4,438 | $54.00 | $239,652.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 3,750 | $0.00 | $0.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | F | 1,718 | $54.73 | $94,026.14 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 1,125 | $0.00 | $0.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 2,625 | $0.00 | $0.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 2,625 | $0.00 | $0.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 3,750 | $0.00 | $0.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 1,125 | $0.00 | $0.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | F | 521 | $54.73 | $28,514.33 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | F | 1,216 | $54.73 | $66,551.68 | View Details Filing |